Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GW685698/GW642444 in COPD
NCT00731822Phase 2Completed
- Sponsor
- GSK
- Start
- Aug 2008
- Primary completion
- Feb 2009
- Modality
- Orthosteric Ligands
- Countries
- 2
01
Overview
A Phase 2 trial of fluticasone, vilanterol in chronic obstructive pulmonary disease (COPD), sponsored by GSK. Started Aug 2008; status: completed.
02
Drugs
fluticasonevilanterol
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT00731822.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00731822.